Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | See Remarks | Aug 15, 2025 | Option/RSU Exercise | - | 244 | - | 7,531 | Aug 19, 2025, 04:07 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | See Remarks | Aug 18, 2025 | Sale | $16.65 | 76 | 1,265 | 7,455 | Aug 19, 2025, 04:07 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | May 15, 2025 | Option/RSU Exercise | - | 244 | - | 7,366 | May 19, 2025, 04:05 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | May 15, 2025 | Sale | $7.28 | 79 | 575 | 7,287 | May 19, 2025, 04:05 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Feb 15, 2025 | Option/RSU Exercise | - | 11,564 | - | 146,756 | Feb 19, 2025, 08:07 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Feb 18, 2025 | Sale | $0.81 | 4,300 | 3,485 | 142,456 | Feb 19, 2025, 08:07 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Nov 15, 2024 | Option/RSU Exercise | - | 2,656 | - | 136,070 | Nov 19, 2024, 04:21 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Nov 18, 2024 | Sale | $0.54 | 878 | 475 | 135,192 | Nov 19, 2024, 04:21 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Oct 27, 2024 | Option/RSU Exercise | - | 13,500 | - | 137,673 | Oct 29, 2024, 06:26 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Oct 28, 2024 | Sale | $0.69 | 4,259 | 2,939 | 133,414 | Oct 29, 2024, 06:26 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Aug 16, 2024 | Sale | $0.84 | 873 | 733 | 124,173 | Aug 19, 2024, 05:48 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Aug 15, 2024 | Option/RSU Exercise | - | 2,656 | - | 125,046 | Aug 19, 2024, 05:48 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | May 15, 2024 | Option/RSU Exercise | - | 2,656 | - | 123,233 | May 17, 2024, 08:14 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | May 15, 2024 | Sale | $0.94 | 843 | 792 | 122,390 | May 17, 2024, 08:14 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Feb 15, 2024 | Option/RSU Exercise | - | 10,625 | - | 124,516 | Feb 16, 2024, 09:48 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Feb 16, 2024 | Sale | $1.08 | 3,939 | 4,254 | 120,577 | Feb 16, 2024, 09:48 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Oct 27, 2023 | Option/RSU Exercise | - | 13,501 | - | 118,047 | Oct 31, 2023, 09:39 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Oct 30, 2023 | Sale | $1.35 | 4,156 | 5,611 | 113,891 | Oct 31, 2023, 09:39 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Jul 05, 2022 | Award/Grant | $3.15 | 63,492 | 200,000 | 104,546 | Jul 06, 2022, 07:29 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Jan 26, 2020 | Option/RSU Exercise | - | 25,000 | - | 41,054 | Jan 28, 2020, 04:06 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Jan 26, 2019 | Option/RSU Exercise | - | 15,000 | - | 21,525 | Jan 29, 2019, 06:55 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | Chief Legal Officer and EVP | Jan 28, 2019 | Sale | $5.75 | 5,471 | 31,478 | 16,054 | Jan 29, 2019, 06:55 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | See Remarks | Jan 26, 2018 | Option/RSU Exercise | - | 10,000 | - | 10,000 | Jan 30, 2018, 08:58 PM | |
MCRB | Seres Therapeutics, Inc. | Thomas Desrosier | See Remarks | Jan 26, 2018 | Sale | $11.02 | 3,475 | 38,295 | 6,525 | Jan 30, 2018, 08:58 PM |